MicroPort® EP OptimAblate™ Tubing Set Receives NMPA Marketing Approval

Shanghai, China, 30 August 2021 — Shanghai MicroPort EP MedTech Co., Ltd., (MicroPort® EP), has recently received marketing approval from China’s National Medical Products Administration (NMPA) for its self-developed OptimAblate™ Tubing Set.

The approved OptimAblate™ Tubing set is designed for use in radiofrequency (RF) ablation procedures – an effective procedure for treating atrial fibrillation. To achieve satisfactory ablation results whilst minimizing or avoiding complications, cold saline is usually used to irrigate the RF ablation catheter during RF ablation procedures.

The OptimAblate™ Tubing set is a disposable infusion tube that can be used in conjunction with MicroPort® EP’s OptimAblate™ Irrigation Pump to accurately infuse saline and other solutions at controlled flow rates into the distal end of irrigation catheters to cool local tissues, minimize the risk of thrombosis, and reduce complications of the procedure. MicroPort® EP’s OptimAblate™ Irrigation Pump and several saline irrigation catheters have already received marketing approval, so the approval of the OptimAblate™ Tubing Set further adds to MicroPort® EP’s diverse product line.

About Atrial Fibrillation

Atrial fibrillation is a common type of cardiac arrhythmia that currently affects nearly 10 million people in China and may cause complications such as stroke and heart failure. The main treatment options for atrial fibrillation include medication therapy and non-medication therapy. As atrial fibrillation cannot be cured by medication and is prone to recurrence, the RF ablation procedure has become an effective means of treatment due to its minor trauma and rapid recovery.

About Shanghai MicroPort EP MedTech Co., Ltd

Shanghai MicroPort EP MedTech Co., Ltd. (MicroPort® EP) is a subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd. (stock code: 0853.HK). In the future, MicroPort® EP will continue to invest in research and development as well as product innovation, to create a product line encompassing active and passive solutions offered by both devices and equipment, with the aim of providing patients and doctors in the field of interventional therapy with accessible total medical solutions centering around precision navigation technologies.